Philips CPAP Cancer Lawsuit News

Phillips CPAP DreamStation Cancer Could Go Undetected For A Decade

The longer sleep apnea machine patients wait to have lung cancer screening, the less likely the disease can be treated successfully

Thursday, September 23, 2021 - CBS News is reporting on the Phillips CPAP DreamStation, a medical device whose malfunction has threatened the lives of millions of Americans. Sleep apnea patients have more questions than answers about the Phillips CPAP recall. Reports are making the rounds in the media that the internal sound reduction foam leaches toxic, possibly carcinogenic particles, chemicals, and gasses directly into its airway and into the nose and lungs, creating the potential for catastrophic health consequences. The Phillips DreamStation sleep apnea device contains a polyester-based polyurethane (PE-PUR) sound abatement foam that degrades and disintegrates when the machine is in use. Phillips CPAP cancer lawsuits claim that using the machine without warning for months, caused them to develop different types of cancer and also lesser but serious lung problems. People that used the machine as a ventilator/sleep apnea device, that suffer from emphysema, asthma, and other lung anomalies, could have been adversely affected immediately, and the malfunction exacerbated their existing health problems. What scares people the most, however, is that most types of lung and other cancer have a latency period of from five to twenty years when there are no outward signs of the disease.

For the 25 million people suffering from sleep apnea, the nature of the condition needs no explanations. For others lucky enough to sleep through the night, sleep apnea patients wake up several times every night from being unable to breathe, a potentially life-threatening situation. If sleep apnea is left untreated, patients could suffocate or suffer a heart attack. CBS News describes the machine, "A continuous positive airway pressure, or CPAP machine, pushes a steady stream of air into a user's nose and mouth, keeping airways open." Imagine the reaction of a user of a sleep apnea machine when they first heard the manufacturer describe the seriousness of the defect in their sleep apnea device. According to CBS, Philips described the proplem as: "sound-dampening foam used in the DreamStation may degrade into particles and "off-gas… chemicals. The FDA says breathing those in could result in serious injury which can be life-threatening or cause permanent impairment ranging from irritation to asthma… or even toxic or carcinogenic effects." Naturally, people who can no longer use their sleep apnea machine suffer from the fallout of not being well-rested enough to lead a normal life. Class action lawsuits seek funding for ongoing medical monitoring for people who have used the Phillips device. More recently, a New York man who had used the Phillips DreamStation device filed a lawsuit claiming that breathing the carcinogenic fumes the machine emitted contributed to his developing prostate cancer. The lawsuit alleges, "Defendants have long known that the polyester-based polyurethane (PE-PUR) sound-abatement foam in Defendants’ CPAP, BiPAP, and mechanical ventilator devices tend to release toxic and carcinogenic microparticles that can be inhaled by users like Plaintiff, causing serious injury or death," according to a report by About Lawsuits.com.

More Recent Philips CPAP Cancer Lawsuit News:

Lawyers for CPAP Cancer Lawsuits

We will represent all persons in involved in a BiPAP or CPAP cancer lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Anyone who developed cancer or another serious side effect as a result of using a Philips CPAP sleep apnea machine or ventilator in --or is a family member of such a person--is eligible to receive a free, no-obligation case review from our attorneys. Simply contact our firm through the online contact form or the chat feature and one of our Philips BiPAP cancer lawyers serving will contact you promptly to discuss your case.



Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.